This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Lek Pharmaceuticals D.d.. Active years: 2012-2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2013
Title: Tomaz Mesar: Innovator in Statin Synthesis
Introduction
Tomaz Mesar is a notable inventor based in Trzin, Slovenia. He has made significant contributions to the field of pharmaceuticals, particularly in the synthesis of statins. With a total of 2 patents to his name, Mesar's work is recognized for its innovative approaches and practical applications.
Latest Patents
Mesar's latest patents focus on the synthesis of statins. One of his key inventions involves a process that utilizes an early intermediate, specifically (4R,6S)-6-(dialkoxymethyl)tetrahydro-2H-pyran-2,4-diol. This intermediate already possesses the desired stereochemistry corresponding to the final statin, enhancing the efficiency of the synthesis process.
Career Highlights
Tomaz Mesar is associated with Lek Pharmaceuticals D.d., a prominent company in the pharmaceutical industry. His work at Lek Pharmaceuticals has allowed him to explore and develop innovative solutions in drug synthesis, particularly in the area of statins.
Collaborations
Mesar has collaborated with several talented individuals in his field, including Zdenko Casar and Gregor Kopitar. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Tomaz Mesar is a distinguished inventor whose work in the synthesis of statins has made a significant impact in the pharmaceutical industry. His innovative approaches and collaborations continue to drive advancements in this important field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile